Side-by-side comparison of AI visibility scores, market position, and capabilities
World's leading motion/control technology manufacturer with $19.9B FY2024 revenue; $8.8B Meggitt aerospace acquisition 2022; Win Strategy driving 21%+ segment margins; serves 400,000+ customers.
Parker Hannifin is the world's leading diversified manufacturer of motion and control technologies, founded in 1917 by Arthur Parker in Cleveland, Ohio where it remains headquartered, trading on NYSE (PH). The company generated approximately $19.9 billion in revenues for fiscal year 2024 (ending June 30) under CEO Jenny Parmentier, who succeeded Tom Williams in 2023 and continues Parker's Win Strategy—a systematic operational framework targeting organic growth, segment operating margin improvement to 21%+, and earnings growth through the cycle. Parker's 2022 acquisition of Meggitt plc for approximately $8.8 billion was the company's largest transaction, adding an aerospace and defense components specialist with complementary positions in thermal management, sealing, and fire protection systems for commercial and military aircraft.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.